Skip to main content
Premium Trial:

Request an Annual Quote

S2 Genomics Strikes Distribution Deal for Sample Prep System With Proteigene in France

NEW YORK — S2 Genomics said on Wednesday that it has signed a distribution agreement for its Singulator 100 tissue dissociation instrument in France with Proteigene.

The Singulator 100 system is designed for the isolation of single cells or nuclei from solid tissue samples for single-cell genomic and cell biology applications. Under the terms of the deal, Saint-Marcel, France-based Proteigene will promote, distribute, and support the instrument and related products in France.

Financial and other terms were not disclosed.

Earlier this month, Livermore, California-based S2 inked a distribution pact for the system in Scandinavia. Proteigene recently signed on as the exclusive distributor in France of Purigen Biosystems' Ionic Purification System for nucleic acid extraction.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.